Wilson Michael J, Koopman-van Gemert Ankie W M M, Harlaar Joris J, Jeekel Johannes, Zwaginga Jaap Jan, Schipperus Martin
TRIP Hemovigilance and Biovigilance Office, Leiden, The Netherlands.
Department of Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
Transfusion. 2018 Oct;58(10):2345-2351. doi: 10.1111/trf.14807. Epub 2018 Sep 10.
There is an increasing awareness to integrate patient blood management (PBM) within routine surgical care. Limited information about the implementation of PBM in colorectal cancer surgery is available. This is curious, as preoperative anemia, associated with increased morbidity, is highly prevalent in colorectal cancer patients. Present study aimed to assess the current PBM strategies in the Netherlands.
An online electronic survey was developed and sent to surgeons of the Dutch Taskforce Coloproctology (177 in total). In addition, for each hospital in which surgery for colorectal cancer surgery is performed (75 in total), the survey was sent to one gastroenterologist and one anesthesiologist. Analyses were performed using descriptive statistics.
A total of 192 physicians responded to the survey (response rate 58.7%). In 73 hospitals (97.3%) the survey was conducted by at least one physician. Regarding the management of a mild-moderate preoperative anemia, no clear policy was reported in half of the hospitals (49.3%). In 38.7% of the hospitals, iron status was indicated to be measured during screening for colorectal cancer. In addition, in only 13.3% of the hospitals, iron status was measured by the anesthesiologist during preoperative assessment.
The Present study shows a distinct variability in PBM practices in colorectal cancer care. Strikingly, this variability was not only seen between, but also within Dutch hospitals, demonstrated by often variable responses from physicians from the same institution. As a result, the present study clearly demonstrates the lack of consensus on PBM, resulting in a suboptimal preoperative blood management strategy.
将患者血液管理(PBM)纳入常规外科护理的意识日益增强。关于PBM在结直肠癌手术中实施情况的信息有限。这很奇怪,因为与发病率增加相关的术前贫血在结直肠癌患者中非常普遍。本研究旨在评估荷兰目前的PBM策略。
开展了一项在线电子调查,并发送给荷兰结直肠外科学组的外科医生(共177名)。此外,对于每家进行结直肠癌手术的医院(共75家),该调查还发送给了一名胃肠病学家和一名麻醉师。使用描述性统计进行分析。
共有192名医生回复了调查(回复率58.7%)。在73家医院(97.3%),至少有一名医生进行了调查。关于轻度至中度术前贫血的管理,一半的医院(49.3%)未报告明确的政策。在38.7%的医院,表明在结直肠癌筛查期间会检测铁状态。此外,仅13.3%的医院在术前评估时由麻醉师检测铁状态。
本研究表明,结直肠癌护理中PBM实践存在明显差异。令人惊讶的是,这种差异不仅在荷兰不同医院之间存在,在同一医院内部也存在,同一机构的医生回答往往各不相同就是证明。因此,本研究清楚地表明在PBM方面缺乏共识,导致术前血液管理策略欠佳。